HEADER    HYDROLASE                               06-JAN-99   1B5F              
TITLE     NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.                          
CAVEAT     1B5F    BMA H 3 HAS WRONG CHIRALITY AT ATOM C1                       
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEIN (CARDOSIN A);                                      
COMPND   3 CHAIN: A, C;                                                         
COMPND   4 EC: 3.4.23.-;                                                        
COMPND   5 OTHER_DETAILS: RESIDUE NAMES ACCORDING TO PEPSIN NUMBERING AFTER     
COMPND   6 A.R.SIELECKI, A.A.FEDOROV, A.BOODHOO, N.S.ANDREEVA, AND M.N.G.JAMES  
COMPND   7 (1990).J.MOL.BIOL. 214, 143-170. NATIVE CARDOSIN A SEQUENCE DIFFERS  
COMPND   8 FROM THAT DEDUCED FROM CDNA THROUGH EXCISION OF THE PSI DOMAIN.      
COMPND   9 MATURE CARDOSIN A IS FOUND IN A TWO CHAIN FORM DUE TO A POST-        
COMPND  10 TRANSLATIONAL CLEAVAGE EVENT. A FIRST, 35 KD CHAIN COMPRISES RESIDUES
COMPND  11 0/1 - 238 AND THE SECOND 15 KD CHAIN COMPRISES RESIDUES 243 - 326.   
COMPND  12 THE ASYMMETRIC UNIT CONTAINS TWO CARDOSIN A MOLECULES. MOLECULE 1 HAS
COMPND  13 BEEN ASSIGNED CHAIN INDICATORS *A* AND *B*, AND MOLECULE 2 HAVE BEEN 
COMPND  14 ASSIGNED CHAIN INDICATORS *C* AND *D*. MOLECULE 1 COMPOSED BY CHAINS 
COMPND  15 A(0-238) AND B (243-326). MOLECULE 2 COMPOSED BY CHAINS C(1-238) AND 
COMPND  16 D (243-326). N-LINKED CARBOHYDRATES (RESIDUES 401-405 A AND 401-406  
COMPND  17 C) ATTACHED TO ASN 67. N-LINKED CARBOHYDRATES (RESIDUES 501-504 B AND
COMPND  18 501-504 D) ATTACHED TO ASN 257.;                                     
COMPND  19 MOL_ID: 2;                                                           
COMPND  20 MOLECULE: PROTEIN (CARDOSIN A);                                      
COMPND  21 CHAIN: B, D;                                                         
COMPND  22 EC: 3.4.23.-;                                                        
COMPND  23 OTHER_DETAILS: RESIDUE NAMES ACCORDING TO PEPSIN NUMBERING AFTER     
COMPND  24 A.R.SIELECKI, A.A.FEDOROV, A.BOODHOO, N.S.ANDREEVA, AND M.N.G.JAMES  
COMPND  25 (1990).J.MOL.BIOL. 214, 143-170. NATIVE CARDOSIN A SEQUENCE DIFFERS  
COMPND  26 FROM THAT DEDUCED FROM CDNA THROUGH EXCISION OF THE PSI DOMAIN.      
COMPND  27 MATURE CARDOSIN A IS FOUND IN A TWO CHAIN FORM DUE TO A POST-        
COMPND  28 TRANSLATIONAL CLEAVAGE EVENT. A FIRST, 35 KD CHAIN COMPRISES RESIDUES
COMPND  29 0/1 - 238 AND THE SECOND 15 KD CHAIN COMPRISES RESIDUES 243 - 326.   
COMPND  30 THE ASYMMETRIC UNIT CONTAINS TWO CARDOSIN A MOLECULES. MOLECULE 1 HAS
COMPND  31 BEEN ASSIGNED CHAIN INDICATORS *A* AND *B*, AND MOLECULE 2 HAVE BEEN 
COMPND  32 ASSIGNED CHAIN INDICATORS *C* AND *D*. MOLECULE 1 COMPOSED BY CHAINS 
COMPND  33 A(0-238) AND B (243-326). MOLECULE 2 COMPOSED BY CHAINS C(1-238) AND 
COMPND  34 D (243-326). N-LINKED CARBOHYDRATES (RESIDUES 401-405 A AND 401-406  
COMPND  35 C) ATTACHED TO ASN 67. N-LINKED CARBOHYDRATES (RESIDUES 501-504 B AND
COMPND  36 501-504 D) ATTACHED TO ASN 257.                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: CYNARA CARDUNCULUS;                             
SOURCE   3 ORGANISM_TAXID: 4265;                                                
SOURCE   4 ORGAN: FLOWER;PISTIL;                                                
SOURCE   5 TISSUE: PAPILLAR EPIDERMIS OF THE STIGMA;                            
SOURCE   6 ORGANELLE: STORAGE VACUOLES;                                         
SOURCE   7 MOL_ID: 2;                                                           
SOURCE   8 ORGANISM_SCIENTIFIC: CYNARA CARDUNCULUS;                             
SOURCE   9 ORGANISM_TAXID: 4265;                                                
SOURCE  10 ORGAN: FLOWER;PISTIL;                                                
SOURCE  11 TISSUE: PAPILLAR EPIDERMIS OF THE STIGMA;                            
SOURCE  12 ORGANELLE: STORAGE VACUOLES                                          
KEYWDS    HYDROLASE, ASPARTIC PROTEINASE                                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    C.FRAZAO,I.BENTO,M.A.CARRONDO                                         
REVDAT   9   30-OCT-24 1B5F    1       REMARK                                   
REVDAT   8   09-AUG-23 1B5F    1       REMARK                                   
REVDAT   7   23-SEP-20 1B5F    1       CAVEAT COMPND HETSYN LINK                
REVDAT   7 2                   1       ATOM                                     
REVDAT   6   29-JUL-20 1B5F    1       COMPND REMARK HETNAM LINK                
REVDAT   6 2                   1       SITE   ATOM                              
REVDAT   5   13-JUL-11 1B5F    1       VERSN                                    
REVDAT   4   24-FEB-09 1B5F    1       VERSN                                    
REVDAT   3   01-APR-03 1B5F    1       JRNL                                     
REVDAT   2   29-DEC-99 1B5F    4       HEADER COMPND REMARK JRNL                
REVDAT   2 2                   4       ATOM   SOURCE SEQRES                     
REVDAT   1   13-JAN-99 1B5F    0                                                
JRNL        AUTH   C.FRAZAO,I.BENTO,J.COSTA,C.M.SOARES,P.VERISSIMO,C.FARO,      
JRNL        AUTH 2 E.PIRES,J.COOPER,M.A.CARRONDO                                
JRNL        TITL   CRYSTAL STRUCTURE OF CARDOSIN A, A GLYCOSYLATED AND          
JRNL        TITL 2 ARG-GLY-ASP-CONTAINING ASPARTIC PROTEINASE FROM THE FLOWERS  
JRNL        TITL 3 OF CYNARA CARDUNCULUS L.                                     
JRNL        REF    J.BIOL.CHEM.                  V. 274 27694 1999              
JRNL        REFN                   ISSN 0021-9258                               
JRNL        PMID   10488111                                                     
JRNL        DOI    10.1074/JBC.274.39.27694                                     
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   I.BENTO,C.FRAZAO,R.COELHO,K.WILSON,Z.DAUTER,M.A.CARRONDO     
REMARK   1  TITL   CRYSTALLIZATION AND PRELIMINARY X-RAY CRYSTALLOGRAPHIC       
REMARK   1  TITL 2 STUDIES OF THE PLANT ASPARTIC PROTEINASE CARDOSIN A          
REMARK   1  REF    ACTA CRYSTALLOGR.,SECT.D      V.  55  1465 1999              
REMARK   1  REFN                   ISSN 0907-4449                               
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   I.BENTO,R.COELHO,C.FRAZAO,J.COSTA,C.FARO,P.VERISSIMO,        
REMARK   1  AUTH 2 E.PIRES,J.COOPER,Z.DAUTER,K.WILSON,M.A.CARRONDO              
REMARK   1  TITL   CRYSTALLIZATION, STRUCTURE SOLUTION, AND INITIAL REFINEMENT  
REMARK   1  TITL 2 OF PLANT CARDOSIN-A                                          
REMARK   1  EDIT   M.N.G.JAMES                                                  
REMARK   1  REF    ADV.EXP.MED.BIOL.             V. 436   445 1998              
REMARK   1  PUBL   NEW YORK AND LONDON : PLENUM PRESS                           
REMARK   1  REFN                   ISSN 0065-2598                               
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.72 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 34.80                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.8                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.206                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.205                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.256                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.800                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 3994                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 83681                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.185                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.184                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.235                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.800                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : 3189                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 66752                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 5000                                          
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 229                                           
REMARK   3   SOLVENT ATOMS      : 528                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 5754.5                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 4964.0                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 18                      
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 23395                   
REMARK   3   NUMBER OF RESTRAINTS                     : 27500                   
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.007                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.025                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.040                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.030                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.038                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.045                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.021                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.000                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.069                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.000                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2          
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: FUCOSE STEREOCHEMICAL TARGET PARAMETERS DERIVED      
REMARK   3                 FROM 1.6 A RESOLUTION STRUCTURE PDB ENTRY 2MYR;      
REMARK   3                 MANNOSE STEREOCHEMICAL TARGET PARAMETERS DERIVED     
REMARK   3                 FROM 1.25 A RESOLUTION STRUCTURE PDB ENTRY 2WEA; N-  
REMARK   3                 ACETYL-GLUCOSAMINE STEREOCHEMICAL TARGET             
REMARK   3                 PARAMETERS DERIVED FROM 1.5 A STRUCTURE PDB ENTRY    
REMARK   3                 1LZB                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS:                                           
REMARK   3  ANISOTROPIC SCALING APPLIED BY THE METHOD OF PARKIN, MOEZZI & HOPE, 
REMARK   3  J.APPL.CRYST.28 (1995)53-56.                                        
REMARK   3  DISORDERED REGIONS THAT WERE MODELED STEREOCHEMICALLY: 75-78 CHAIN  
REMARK   3  A AND 75-79 CHAIN C (FLAP); 46-46                                   
REMARK   3  CHAIN A AND 46-47 CHAIN C; 159-160 AND 160B CHAIN A.                
REMARK   3                                                                      
REMARK   3  DISORDERED REGIONS THAT WERE MODELED STEREOCHEMICALLY:              
REMARK   3  75-78 CHAIN A AND 75-79 CHAIN C (FLAP); 46-46 CHAIN A AND           
REMARK   3  46-47 CHAIN C; 159-160 AND 160B CHAIN A.                            
REMARK   4                                                                      
REMARK   4 1B5F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB.                               
REMARK 100 THE DEPOSITION ID IS D_1000008008.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 05-APR-97                          
REMARK 200  TEMPERATURE           (KELVIN) : 100.0                              
REMARK 200  PH                             : 5.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : EMBL/DESY, HAMBURG                 
REMARK 200  BEAMLINE                       : X11                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9091                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 84399                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.720                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 34.780                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 96.9                               
REMARK 200  DATA REDUNDANCY                : 11.30                              
REMARK 200  R MERGE                    (I) : 0.06200                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 15.9000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.72                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.75                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 99.3                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 2.90                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.41300                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 2.500                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: AMORE                                                 
REMARK 200 STARTING MODEL: HUMAN CATHEPSIN D (PDB ENTRY 1LYB))                  
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 46.00                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: LYOPHILIZED PROTEIN DISSOLVED IN WATER   
REMARK 280  TO 12 MG/ML, SITTING DROPS OF PROTEIN SOLUTION AN ALIQUOTA OF       
REMARK 280  PRECIPITANT SOLUTION, COMPOSED OF PEG 4 K 40%, SODIUM CITRATE       
REMARK 280  BUFFER 0.1 M AND AMMONIUM ACETATE 0.2 M, PH 5.5                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y,-Z                                                 
REMARK 290       3555   X+1/2,Y+1/2,Z                                           
REMARK 290       4555   -X+1/2,Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       58.48200            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       43.59300            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       58.48200            
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       43.59300            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2, 3                                                 
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H                
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 8360 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 14300 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 3                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 8730 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 14450 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 375                                                                      
REMARK 375 SPECIAL POSITION                                                     
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS            
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL          
REMARK 375 POSITIONS.                                                           
REMARK 375                                                                      
REMARK 375 ATOM RES CSSEQI                                                      
REMARK 375      HOH D 465  LIES ON A SPECIAL POSITION.                          
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 MATURE CARDOSIN A IS FOUND IN A TWO CHAIN FORM DUE TO A              
REMARK 400 POST-TRANSLATIONAL CLEAVAGE EVENT. A FIRST, 35 KD CHAIN              
REMARK 400 COMPRISES RESIDUES 0/1 - 238 AND THE SECOND 15 KD CHAIN              
REMARK 400 COMPRISES RESIDUES 243 - 326. THE ASYMMETRIC UNIT                    
REMARK 400 CONTAINS TWO CARDOSIN A MOLECULES. MOLECULE 1 HAS BEEN               
REMARK 400 ASSIGNED CHAIN INDICATORS *A* AND *B*, AND MOLECULE 2                
REMARK 400 HAVE BEEN ASSIGNED CHAIN INDICATORS *C* AND *D*.                     
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     GLY C     0                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A 149   CD  -  NE  -  CZ  ANGL. DEV. =   8.6 DEGREES          
REMARK 500    GLY C 204A  C   -  N   -  CA  ANGL. DEV. =  13.4 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    SER A   1      -25.58    -39.81                                   
REMARK 500    ASP A  11        7.50     59.55                                   
REMARK 500    LYS A  44       34.13    -90.75                                   
REMARK 500    LYS A  44       37.75    -90.75                                   
REMARK 500    CYS A  45      132.81    -37.94                                   
REMARK 500    ASN A  67      -69.55   -131.19                                   
REMARK 500    THR A  77      -54.62   -159.65                                   
REMARK 500    HIS A 114       60.69   -108.97                                   
REMARK 500    THR A 128      -86.09   -114.07                                   
REMARK 500    TYR A 188      -65.74   -147.54                                   
REMARK 500    LEU B 295      -33.27     78.38                                   
REMARK 500    LYS C  44       27.77    -78.65                                   
REMARK 500    ASN C  67      -64.18   -132.92                                   
REMARK 500    TYR C  75     -171.54    -65.79                                   
REMARK 500    THR C  77      -52.88   -151.79                                   
REMARK 500    THR C 128      -85.35   -118.75                                   
REMARK 500    GLU C 160A      30.33    -87.00                                   
REMARK 500    TYR C 188      -63.10   -142.75                                   
REMARK 500    LEU C 220     -167.13   -109.35                                   
REMARK 500    GLU D 244       51.10     74.56                                   
REMARK 500    LEU D 295      -50.96     73.87                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: 1                                                   
REMARK 800 EVIDENCE_CODE: AUTHOR                                                
REMARK 800 SITE_DESCRIPTION: ASPARTIC PROTEINASE CATALYTIC SITE WATER 1014      
REMARK 800  ASSOCIATED TO CHAIN A CATALYTIC SITE WATER 1035 ASSOCIATED TO       
REMARK 800  CHAIN C CATALYTIC SITE                                              
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: 2                                                   
REMARK 800 EVIDENCE_CODE: AUTHOR                                                
REMARK 800 SITE_DESCRIPTION: N-GLYCOSYLATION SITE ON CHAIN A, ASN67: (A1->3)    
REMARK 800  -MAN405 | ASN67-NAG401-(B1->4)-NAG403-(B1->4)-MAN404 | (A1->3)      
REMARK 800  FUC402                                                              
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: 3                                                   
REMARK 800 EVIDENCE_CODE: AUTHOR                                                
REMARK 800 SITE_DESCRIPTION: N-GLYCOSYLATION SITE ON CHAIN B, ASN257: ASN257    
REMARK 800  -NAG501-(B1->4)-NAG503-(B1->4)-MAN504 | (A1->3)-FUC502              
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: 4                                                   
REMARK 800 EVIDENCE_CODE: AUTHOR                                                
REMARK 800 SITE_DESCRIPTION: N-GLYCOSYLATION SITE ON CHAIN C, ASN67: (A1->3)    
REMARK 800  -MAN405 | ASN67-NAG401-(B1->4)-NAG403-(B1->4)-MAN404 | | (A1->3)-   
REMARK 800  FUC402 (A1->6)-MAN406                                               
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: 5                                                   
REMARK 800 EVIDENCE_CODE: AUTHOR                                                
REMARK 800 SITE_DESCRIPTION: N-GLYCOSYLATION SITE ON CHAIN D, ASN257: ASN257    
REMARK 800  -NAG501-(B1->4)-NAG503-(B1->4)-MAN504 | (A1->3)-FUC502              
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: 6                                                   
REMARK 800 EVIDENCE_CODE: AUTHOR                                                
REMARK 800 SITE_DESCRIPTION: NULL                                               
DBREF  1B5F A    0   238  EMBL   CAB4134  AJ132884        71    309             
DBREF  1B5F B  243   326  EMBL   CAB4134  AJ132884       418    504             
DBREF  1B5F C    0   238  EMBL   CAB4134  AJ132884        71    309             
DBREF  1B5F D  243   326  EMBL   CAB4134  AJ132884       418    504             
SEQRES   1 A  239  GLY SER ALA VAL VAL ALA LEU THR ASN ASP ARG ASP THR          
SEQRES   2 A  239  SER TYR PHE GLY GLU ILE GLY ILE GLY THR PRO PRO GLN          
SEQRES   3 A  239  LYS PHE THR VAL ILE PHE ASP THR GLY SER SER VAL LEU          
SEQRES   4 A  239  TRP VAL PRO SER SER LYS CYS ILE ASN SER LYS ALA CYS          
SEQRES   5 A  239  ARG ALA HIS SER MET TYR GLU SER SER ASP SER SER THR          
SEQRES   6 A  239  TYR LYS GLU ASN GLY THR PHE GLY ALA ILE ILE TYR GLY          
SEQRES   7 A  239  THR GLY SER ILE THR GLY PHE PHE SER GLN ASP SER VAL          
SEQRES   8 A  239  THR ILE GLY ASP LEU VAL VAL LYS GLU GLN ASP PHE ILE          
SEQRES   9 A  239  GLU ALA THR ASP GLU ALA ASP ASN VAL PHE LEU HIS ARG          
SEQRES  10 A  239  LEU PHE ASP GLY ILE LEU GLY LEU SER PHE GLN THR ILE          
SEQRES  11 A  239  SER VAL PRO VAL TRP TYR ASN MET LEU ASN GLN GLY LEU          
SEQRES  12 A  239  VAL LYS GLU ARG ARG PHE SER PHE TRP LEU ASN ARG ASN          
SEQRES  13 A  239  VAL ASP GLU GLU GLU GLY GLY GLU LEU VAL PHE GLY GLY          
SEQRES  14 A  239  LEU ASP PRO ASN HIS PHE ARG GLY ASP HIS THR TYR VAL          
SEQRES  15 A  239  PRO VAL THR TYR GLN TYR TYR TRP GLN PHE GLY ILE GLY          
SEQRES  16 A  239  ASP VAL LEU ILE GLY ASP LYS SER THR GLY PHE CYS ALA          
SEQRES  17 A  239  PRO GLY CYS GLN ALA PHE ALA ASP SER GLY THR SER LEU          
SEQRES  18 A  239  LEU SER GLY PRO THR ALA ILE VAL THR GLN ILE ASN HIS          
SEQRES  19 A  239  ALA ILE GLY ALA ASN                                          
SEQRES   1 B   87  GLU GLU LEU GLN VAL ASP CYS ASN THR LEU SER SER MET          
SEQRES   2 B   87  PRO ASN VAL SER PHE THR ILE GLY GLY LYS LYS PHE GLY          
SEQRES   3 B   87  LEU THR PRO GLU GLN TYR ILE LEU LYS VAL GLY LYS GLY          
SEQRES   4 B   87  GLU ALA THR GLN CYS ILE SER GLY PHE THR ALA MET ASP          
SEQRES   5 B   87  ALA THR LEU LEU GLY PRO LEU TRP ILE LEU GLY ASP VAL          
SEQRES   6 B   87  PHE MET ARG PRO TYR HIS THR VAL PHE ASP TYR GLY ASN          
SEQRES   7 B   87  LEU LEU VAL GLY PHE ALA GLU ALA ALA                          
SEQRES   1 C  239  GLY SER ALA VAL VAL ALA LEU THR ASN ASP ARG ASP THR          
SEQRES   2 C  239  SER TYR PHE GLY GLU ILE GLY ILE GLY THR PRO PRO GLN          
SEQRES   3 C  239  LYS PHE THR VAL ILE PHE ASP THR GLY SER SER VAL LEU          
SEQRES   4 C  239  TRP VAL PRO SER SER LYS CYS ILE ASN SER LYS ALA CYS          
SEQRES   5 C  239  ARG ALA HIS SER MET TYR GLU SER SER ASP SER SER THR          
SEQRES   6 C  239  TYR LYS GLU ASN GLY THR PHE GLY ALA ILE ILE TYR GLY          
SEQRES   7 C  239  THR GLY SER ILE THR GLY PHE PHE SER GLN ASP SER VAL          
SEQRES   8 C  239  THR ILE GLY ASP LEU VAL VAL LYS GLU GLN ASP PHE ILE          
SEQRES   9 C  239  GLU ALA THR ASP GLU ALA ASP ASN VAL PHE LEU HIS ARG          
SEQRES  10 C  239  LEU PHE ASP GLY ILE LEU GLY LEU SER PHE GLN THR ILE          
SEQRES  11 C  239  SER VAL PRO VAL TRP TYR ASN MET LEU ASN GLN GLY LEU          
SEQRES  12 C  239  VAL LYS GLU ARG ARG PHE SER PHE TRP LEU ASN ARG ASN          
SEQRES  13 C  239  VAL ASP GLU GLU GLU GLY GLY GLU LEU VAL PHE GLY GLY          
SEQRES  14 C  239  LEU ASP PRO ASN HIS PHE ARG GLY ASP HIS THR TYR VAL          
SEQRES  15 C  239  PRO VAL THR TYR GLN TYR TYR TRP GLN PHE GLY ILE GLY          
SEQRES  16 C  239  ASP VAL LEU ILE GLY ASP LYS SER THR GLY PHE CYS ALA          
SEQRES  17 C  239  PRO GLY CYS GLN ALA PHE ALA ASP SER GLY THR SER LEU          
SEQRES  18 C  239  LEU SER GLY PRO THR ALA ILE VAL THR GLN ILE ASN HIS          
SEQRES  19 C  239  ALA ILE GLY ALA ASN                                          
SEQRES   1 D   87  GLU GLU LEU GLN VAL ASP CYS ASN THR LEU SER SER MET          
SEQRES   2 D   87  PRO ASN VAL SER PHE THR ILE GLY GLY LYS LYS PHE GLY          
SEQRES   3 D   87  LEU THR PRO GLU GLN TYR ILE LEU LYS VAL GLY LYS GLY          
SEQRES   4 D   87  GLU ALA THR GLN CYS ILE SER GLY PHE THR ALA MET ASP          
SEQRES   5 D   87  ALA THR LEU LEU GLY PRO LEU TRP ILE LEU GLY ASP VAL          
SEQRES   6 D   87  PHE MET ARG PRO TYR HIS THR VAL PHE ASP TYR GLY ASN          
SEQRES   7 D   87  LEU LEU VAL GLY PHE ALA GLU ALA ALA                          
MODRES 1B5F ASN A   67  ASN  GLYCOSYLATION SITE                                 
MODRES 1B5F ASN B  257  ASN  GLYCOSYLATION SITE                                 
MODRES 1B5F ASN C   67  ASN  GLYCOSYLATION SITE                                 
MODRES 1B5F ASN D  257  ASN  GLYCOSYLATION SITE                                 
HET    NAG  E   1      14                                                       
HET    NAG  E   2      14                                                       
HET    BMA  E   3      11                                                       
HET    MAN  E   4      11                                                       
HET    FUC  E   5      10                                                       
HET    NAG  F   1      18                                                       
HET    NAG  F   2      14                                                       
HET    BMA  F   3      11                                                       
HET    FUC  F   4      10                                                       
HET    NAG  G   1      14                                                       
HET    NAG  G   2      14                                                       
HET    BMA  G   3      11                                                       
HET    MAN  G   4      11                                                       
HET    MAN  G   5      11                                                       
HET    FUC  G   6      10                                                       
HET    NAG  H   1      14                                                       
HET    NAG  H   2      14                                                       
HET    BMA  H   3      11                                                       
HET    FUC  H   4      20                                                       
HETNAM     NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE                         
HETNAM     BMA BETA-D-MANNOPYRANOSE                                             
HETNAM     MAN ALPHA-D-MANNOPYRANOSE                                            
HETNAM     FUC ALPHA-L-FUCOPYRANOSE                                             
HETSYN     NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-           
HETSYN   2 NAG  D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-          
HETSYN   3 NAG  2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE                         
HETSYN     BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE                               
HETSYN     MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE                              
HETSYN     FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L-              
HETSYN   2 FUC  FUCOSE; FUCOSE                                                  
FORMUL   5  NAG    8(C8 H15 N O6)                                               
FORMUL   5  BMA    4(C6 H12 O6)                                                 
FORMUL   5  MAN    3(C6 H12 O6)                                                 
FORMUL   5  FUC    4(C6 H12 O5)                                                 
FORMUL   9  HOH   *528(H2 O)                                                    
HELIX    1   1 LYS A   48  ARG A   51  1                                   4    
HELIX    2   2 SER A   58  ASP A   60  5                                   3    
HELIX    3   3 ASP A  109  PHE A  112  1                                   4    
HELIX    4   4 VAL A  136  ASN A  142  1                                   7    
HELIX    5   5 PRO A  172  HIS A  174  5                                   3    
HELIX    6   6 THR A  225  ALA A  234  1                                  10    
HELIX    7   7 CYS B  249  SER B  254  5                                   6    
HELIX    8   8 PRO B  271  TYR B  274  1                                   4    
HELIX    9   9 ASP B  303  PRO B  308  1                                   6    
HELIX   10  10 LYS C   48  ARG C   51  1                                   4    
HELIX   11  11 SER C   58  ASP C   60  5                                   3    
HELIX   12  12 ASP C  109  PHE C  112  1                                   4    
HELIX   13  13 VAL C  136  ASN C  142  1                                   7    
HELIX   14  14 PRO C  172  HIS C  174  5                                   3    
HELIX   15  15 THR C  225  ILE C  235  1                                  11    
HELIX   16  16 CYS D  249  SER D  254  5                                   6    
HELIX   17  17 PRO D  271  TYR D  274  1                                   4    
HELIX   18  18 ASP D  303  PRO D  308  1                                   6    
SHEET    1   A 3 ALA A   2  LEU A   6  0                                        
SHEET    2   A 3 GLY A 163  PHE A 167 -1  N  PHE A 167   O  ALA A   2           
SHEET    3   A 3 PHE A 151  LEU A 155 -1  N  TRP A 154   O  GLU A 164           
SHEET    1   B 4 THR A   7  ASP A   9  0                                        
SHEET    2   B 4 SER A  13  ILE A  20 -1  N  PHE A  15   O  THR A   7           
SHEET    3   B 4 GLN A  25  ASP A  32 -1  N  VAL A  29   O  GLY A  16           
SHEET    4   B 4 GLY A 119  GLY A 122  1  N  GLY A 119   O  ILE A  30           
SHEET    1   C 4 TRP A  39  PRO A  41  0                                        
SHEET    2   C 4 GLN A  99  GLU A 107  1  N  ILE A 102   O  VAL A  40           
SHEET    3   C 4 SER A  79  ASP A  87 -1  N  ASP A  87   O  GLN A  99           
SHEET    4   C 4 PHE A  70  ILE A  74 -1  N  ILE A  73   O  ILE A  80           
SHEET    1   D 2 VAL A  89  ILE A  91  0                                        
SHEET    2   D 2 LEU A  94  VAL A  96 -1  N  VAL A  96   O  VAL A  89           
SHEET    1   E 2 GLN A 191  ILE A 194  0                                        
SHEET    2   E 2 CYS A 210  PHE A 213 -1  N  ALA A 212   O  PHE A 192           
SHEET    1   F 2 VAL B 258  ILE B 262  0                                        
SHEET    2   F 2 LYS B 265  LEU B 269 -1  N  LEU B 269   O  VAL B 258           
SHEET    1   G 2 ILE B 275  VAL B 278  0                                        
SHEET    2   G 2 GLN B 281  SER B 284 -1  N  ILE B 283   O  LEU B 276           
SHEET    1   H 2 TYR B 309  ASP B 314  0                                        
SHEET    2   H 2 LEU B 319  GLU B 324 -1  N  ALA B 323   O  HIS B 310           
SHEET    1   I 3 ALA C   2  LEU C   6  0                                        
SHEET    2   I 3 GLY C 163  PHE C 167 -1  N  PHE C 167   O  ALA C   2           
SHEET    3   I 3 PHE C 151  LEU C 155 -1  N  TRP C 154   O  GLU C 164           
SHEET    1   J 2 THR C   7  ASP C   9  0                                        
SHEET    2   J 2 SER C  13  PHE C  15 -1  N  PHE C  15   O  THR C   7           
SHEET    1   K 3 GLY C  16  ILE C  20  0                                        
SHEET    2   K 3 GLN C  25  ASP C  32 -1  N  VAL C  29   O  GLY C  16           
SHEET    3   K 3 GLY C 119  GLY C 122  1  N  GLY C 119   O  ILE C  30           
SHEET    1   L 4 TRP C  39  PRO C  41  0                                        
SHEET    2   L 4 GLN C  99  GLU C 107  1  N  ILE C 102   O  VAL C  40           
SHEET    3   L 4 SER C  79  ASP C  87 -1  N  ASP C  87   O  GLN C  99           
SHEET    4   L 4 PHE C  70  ILE C  74 -1  N  ILE C  73   O  ILE C  80           
SHEET    1   M 2 VAL C  89  ILE C  91  0                                        
SHEET    2   M 2 LEU C  94  VAL C  96 -1  N  VAL C  96   O  VAL C  89           
SHEET    1   N 2 GLN C 191  ILE C 194  0                                        
SHEET    2   N 2 CYS C 210  PHE C 213 -1  N  ALA C 212   O  PHE C 192           
SHEET    1   O 2 VAL D 258  ILE D 262  0                                        
SHEET    2   O 2 LYS D 265  LEU D 269 -1  N  LEU D 269   O  VAL D 258           
SHEET    1   P 2 ILE D 275  VAL D 278  0                                        
SHEET    2   P 2 GLN D 281  SER D 284 -1  N  ILE D 283   O  LEU D 276           
SHEET    1   Q 2 TYR D 309  ASP D 314  0                                        
SHEET    2   Q 2 LEU D 319  GLU D 324 -1  N  ALA D 323   O  HIS D 310           
SSBOND   1 CYS A   45    CYS A   50                          1555   1555  2.03  
SSBOND   2 CYS A  206    CYS A  210                          1555   1555  2.07  
SSBOND   3 CYS B  249    CYS B  282                          1555   1555  2.08  
SSBOND   4 CYS C   45    CYS C   50                          1555   1555  2.04  
SSBOND   5 CYS C  206    CYS C  210                          1555   1555  2.06  
SSBOND   6 CYS D  249    CYS D  282                          1555   1555  2.06  
LINK         ND2 ASN A  67                 C1  NAG E   1     1555   1555  1.47  
LINK         ND2 ASN B 257                 C1  NAG F   1     1555   1555  1.45  
LINK         ND2 ASN C  67                 C1  NAG G   1     1555   1555  1.48  
LINK         ND2 ASN D 257                 C1  NAG H   1     1555   1555  1.46  
LINK         O4  NAG E   1                 C1  NAG E   2     1555   1555  1.39  
LINK         O3  NAG E   1                 C1  FUC E   5     1555   1555  1.43  
LINK         O4  NAG E   2                 C1  BMA E   3     1555   1555  1.40  
LINK         O3  BMA E   3                 C1  MAN E   4     1555   1555  1.41  
LINK         O4  NAG F   1                 C1  NAG F   2     1555   1555  1.39  
LINK         O3  NAG F   1                 C1  FUC F   4     1555   1555  1.43  
LINK         O4  NAG F   2                 C1  BMA F   3     1555   1555  1.39  
LINK         O4  NAG G   1                 C1  NAG G   2     1555   1555  1.39  
LINK         O3  NAG G   1                 C1  FUC G   6     1555   1555  1.43  
LINK         O4  NAG G   2                 C1  BMA G   3     1555   1555  1.40  
LINK         O3  BMA G   3                 C1  MAN G   4     1555   1555  1.41  
LINK         O6  BMA G   3                 C1  MAN G   5     1555   1555  1.41  
LINK         O4  NAG H   1                 C1  NAG H   2     1555   1555  1.39  
LINK         O3  NAG H   1                 C1 AFUC H   4     1555   1555  1.42  
LINK         O3  NAG H   1                 C1 BFUC H   4     1555   1555  1.42  
LINK         O4  NAG H   2                 C1  BMA H   3     1555   1555  1.39  
CISPEP   1 THR A   22    PRO A   23          0        -3.84                     
CISPEP   2 THR C   22    PRO C   23          0         1.24                     
SITE     1   1  2 ASP A  32  ASP A 215                                          
SITE     1   2  1 ASN A  67                                                     
SITE     1   3  1 ASN B 257                                                     
SITE     1   4  2 ASP C  32  ASP C 215                                          
SITE     1   5  1 ASN C  67                                                     
SITE     1   6  1 ASN D 257                                                     
CRYST1  116.964   87.186   81.303  90.00 104.43  90.00 C 1 2 1       8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.008550  0.000000  0.002200        0.00000                         
SCALE2      0.000000  0.011470  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.012700        0.00000                         
MTRIX1   1 -0.883650 -0.136860  0.447690       11.51360    1                    
MTRIX2   1  0.170040 -0.984830  0.034560       29.86930    1                    
MTRIX3   1  0.436170  0.106660  0.893520       -9.25410    1